Variant Bio is developing therapies that will improve global health by studying the genes of people who are outliers for medically relevant traits.
| Website | http://www.variantbio.com |
| Employees | 38 (30 on RocketReach) |
| Founded | 2018 |
| Address | 188 E Blaine St Suite 126, Seattle, Washington 98102, US |
| Technologies |
JavaScript
,
Twitter
,
Google Tag Manager
+14 more
(view full list)
|
| Industry | Biotechnology Research, Drug Discovery, Biotechnology |
| Keywords | Precision Medicine, Gene Therapy, Rare Diseases, Human Genetics, Personalized Medicine, Genome Editing, Drug Discovery, Genetic Engineering, Genetic Research, Pharmaceutical Research, Therapeutics, Molecular Biology, Biotechnology, Biomedical Research, Biopharma, Clinical Trials, Medical Research, Health Technology, Life Sciences |
| Competitors | Amgen, Regeneron, Vertex Pharmaceuticals, Illumina, Moderna Therapeutics, Alnylam Pharmaceuticals, CRISPR Therapeutics, bluebird bio, Editas Medicine, Sangamo Therapeutics, Inc. +36 more (view full list) |
Looking for a particular Variant Bio employee's phone or email?
Variant Bio Questions
Andrew Farnum is the CEO of Variant Bio.
30 people are employed at Variant Bio.
Variant Bio is based in Seattle, Washington.
Top Variant Bio Employees
-
Andrew Farnum
Chief Executive Officer at Variant Bio
Seattle, WA, US22 -
11
-
55+
-
Gautam Mehta
Vice President, Head of Partnerships at Variant Bio
Seattle, WA, US33 -
45
-
Leslie Hepner
Vice President Operations at Variant Bio
Seattle, WA, US24 -
Sharon Crugnale
SVP Development Operations at Variant Bio
Boston, MA, US35 -
Rob Flickenger
VP, Research Infrastructure at Variant Bio
Kirkland, WA, US15+
Related Companies
G2Crowd Trusted
300K+
Plugin Users
